Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

19.84USD
17 Jun 2019
Change (% chg)

$0.47 (+2.43%)
Prev Close
$19.37
Open
$19.58
Day's High
$19.86
Day's Low
$19.00
Volume
174,050
Avg. Vol
218,086
52-wk High
$24.30
52-wk Low
$12.20

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 2.25
Market Cap(Mil.): $769.99
Shares Outstanding(Mil.): 39.75
Dividend: --
Yield (%): --

Financials

  CARA.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -2.10 -- --
ROI: -78.44 7.69 12.16
ROE: -84.88 8.19 16.93

Earnings vs. Estimates